4Front Introduces Initial Brightleaf (formerly Cannex) Brands to Massachusetts

The introduction of Marmas and Pebbles branded edibles to the Massachusetts market marks the initial implementation of Cannex’s operational capabilities in a new market (outside Washington State)

Adult-use approval at two Massachusetts facilities anticipated imminently

VANCOUVER, B.C., and PHOENIX, Ariz., October 21, 2019 – 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”) announces that, following the closing of its merger with Cannex on July 31, the company has moved quickly to take Cannex’s battle-tested operating capabilities, now part of 4Front’s production and manufacturing division Brightleaf, and apply them to the Massachusetts market.

“To say I am proud of my team is an understatement,” said Leo Gontmakher, 4Front COO. “Taking advantage of our pre-merger planning work, we formally took over 4Front’s production and processing operations in August. By late September, we had introduced Marmas and Pebbles, two of our most successful edibles brands, to the Massachusetts’ medical cannabis market. Most importantly to me, we successfully replicated the low-cost production methods we developed in Washington.

“In addition, we started the first fully supervised harvest based on our improvements to our Worcester, Mass., facility—the processes and genetics are proving to be robust for yield and the initial quality looks great. There is much more work to do, but to see the team coming together and the tangible operational progress gives me confidence in our capabilities to execute on our plans to bring our efficient production of consistent, quality products to new markets.”

“We are executing against a simple strategy: bringing highly efficient and battle-tested operating capabilities to nascent markets,” said Josh Rosen, CEO of 4Front. “In this case, Leo and team were able to quickly implement these capabilities in a new market to achieve stellar initial results.”

Regarding adult-use approval for its facilities in Massachusetts, Rosen said, “We are appreciatively entering what appears to be the ‘final final’ stages of obtaining adult-use permission in our Massachusetts facilities in Georgetown and Worcester. If matters proceed as anticipated, we will be selling into the adult-use market in a matter of weeks, not months.”

About 4Front Ventures Corp.
4Front is a cannabis company designed for long-term success and built upon battle-tested operating capabilities at scale, experienced and committed leadership, a strategic asset base, and a commitment to being a magnet for talent. From plant genetics to the cannabis retail experience, 4Front’s team applies expertise across the value chain. 4Front has invested heavily to assemble a comprehensive collection of management skills and hands-on operating expertise to capitalize on the unique growth opportunity being afforded by the increased legalization of cannabis. For more information, visit 4Front’s website.

Investor Contact
Andrew Thut, Chief Investment Officer
IR@4frontventures.com
602-633-3067

Media Contact
Anne Donohoe / Nick Opich
KCSA Strategic Communications
adonohoe@kcsa.com / nopich@kcsa.com
212-896-1265 / 212-896-1206

This news release was prepared by management of 4Front Ventures, which takes full responsibility for its contents. The Canadian Securities Exchange (“CSE”) has not reviewed and does not accept responsibility for the adequacy of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in 4Front Ventures’ periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to future developments and the business and operations of 4Front Ventures, developments with respect to legislative developments in the United States and the proposed trading dated of the resulting issuer.

Although 4Front Ventures has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under U.S. federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. 4Front Ventures disclaims any intention or obligation to update or revise such information, except as required by applicable law, and 4Front Ventures does not assume any liability for disclosure relating to any other company mentioned herein.

The post 4Front Introduces Initial Brightleaf (formerly Cannex) Brands to Massachusetts appeared first on 4Front.

from 4Front https://ift.tt/2o9LE6s

4Front Hires Chief Human Performance Officer to Drive Leadership and Employee Development

Alicia Mandel brings 30+ years of experience in developing scalable talent-development programs for organizations such as American Express, University of Phoenix, and the U.S. Olympic Committee

VANCOUVER, B.C., and PHOENIX, Ariz., October 15, 2019 – 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”) has hired Alicia Mandel as 4Front’s first Chief Human Performance Officer. Her addition to the team furthers 4Front’s commitment to developing high-caliber talent and attracting the best people from within and outside the cannabis industry.

“I’m very excited about welcoming Alicia into the 4Front family,” 4Front CEO Josh Rosen said. “I know executives who have gone through her leadership development program and, after reaching out to her, it quickly became clear we have a shared belief in what developing great talent means. 4Front will benefit immensely from her innovative thinking on what effective leadership looks like and her experience building scalable talent infrastructure for organizations such as Citi and the U.S. Olympic Committee.”

Ms. Mandel comes to 4Front with three decades of corporate training and employee engagement experience. She has held positions at American Express, Apollo Education Group/University of Phoenix, the U.S. Olympic Committee, and Citi, among others. As a consultant, she’s also worked with companies such as Oracle, Adobe, Nike, and Microsoft, on executive coaching, team development, and helping align a company’s people strategy with its business strategy.

“While my consulting business was growing strong, I couldn’t pass up the opportunity to build an industry-leading executive and employee development program at a company that’s blazing a trail in a brand new industry,” Ms. Mandel said. “I look forward to developing 4Front’s leadership capacity and helping build a strong and deep bench of talent, as well as driving an intentional culture that will create an environment where people can succeed as they propel the organization towards its business objectives.”

Alicia Mandel’s Bio
Ms. Mandel spent the first 17 years of her career in New York City working for two large financial organizations and learning “the right way and the wrong way to do things,” she says. She began her career at what was then Citibank, becoming one of the first employees in the bank’s new corporate training department. As Citi’s Manager of Learning and Development, she helped develop the bank’s training capabilities to support talent development across its global footprint. Following Citi, she spent 10 years at American Express in a variety of HR roles across business functions, eventually earning the title of Director of Employee Engagement. Later, the U.S. Olympic Committee hired her to build “Olympic University,” which was an internal and external learning and leadership development program designed to build leadership skills across the committee and all of the sports’ national governing bodies. Having successfully developed that program, she was asked to join the USOC full-time as its Acting Chief Human Resources Officer. She also has experience working for a high-growth startup, spending three years building a scalable talent infrastructure for Asurion, which grew from 500 employees to 5,000 while she was there. More recently, Ms. Mandel served as Chief Learning Officer for Apollo Education Group, the for-profit education company most well-known for the University of Phoenix. She’s also a successful business owner, having co-founded Medius Advisory Group in 2016 to provide corporate clients with leadership training and team development services. Her clients have included Adobe, Microsoft, Nike, and Oracle. Ms. Mandel lives in Phoenix.

Alicia Mandel, 4Front’s Chief Human Performance Officer

About 4Front Ventures Corp.
4Front is a cannabis company designed for long-term success and built upon battle-tested operating capabilities at scale, experienced and committed leadership, a strategic asset base, and a commitment to being a magnet for talent. From plant genetics to the cannabis retail experience, 4Front’s team applies expertise across the value chain. 4Front has invested heavily to assemble a comprehensive collection of management skills and hands-on operating expertise to capitalize on the unique growth opportunity being afforded by the increased legalization of cannabis. For more information, visit 4Front’s website.

Investor Contact
Andrew Thut, Chief Investment Officer
IR@4frontventures.com
602-633-3067

Media Contact
Anne Donohoe / Nick Opich
KCSA Strategic Communications
adonohoe@kcsa.com / nopich@kcsa.com
212-896-1265 / 212-896-

This news release was prepared by management of 4Front Ventures, which takes full responsibility for its contents. The Canadian Securities Exchange (“CSE”) has not reviewed and does not accept responsibility for the adequacy of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in 4Front Ventures’ periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to future developments and the business and operations of 4Front Ventures, developments with respect to legislative developments in the United States and the proposed trading dated of the resulting issuer.

Although 4Front Ventures has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under U.S. federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. 4Front Ventures disclaims any intention or obligation to update or revise such information, except as required by applicable law, and 4Front Ventures does not assume any liability for disclosure relating to any other company mentioned herein.

The post 4Front Hires Chief Human Performance Officer to Drive Leadership and Employee Development appeared first on 4Front.

from 4Front https://ift.tt/2Bd5Ffl

4Front Announces Upcoming Conference Participation

Company to participate in Canaccord’s U.S. Cannabis Symposium, NCIA California Cannabis Business Conference, Arcview Investor Forum, IC3, and the Benzinga Cannabis Capital Conference in October

VANCOUVER, British Columbia and PHOENIX, October 2, 2019 — 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company“) today announced that a number of its executives, including President Kris Krane and Chief Investment Officer Andrew Thut, will attend several industry events during the month of October.

Company executives will participate in the following events:

Canaccord’s U.S. Cannabis Symposium
On Oct. 3, Mr. Thut will give a company presentation at 3:10 p.m. ET at the Sheraton Centre Toronto Hotel in Toronto. You can view the company’s presentation here.

Arcview Investor Forum
On Oct. 3, Mr. Krane will participate in one-on-one meetings at Convene’s One Liberty Plaza location in New York City.

NCIA California Cannabis Business Conference
On Oct. 9, Josh Krane, Senior Director of Business Development in California, will be available to participate in one-on-one meetings at the Long Beach Convention Center in Long Beach, Calif.

Institutional Capital & Cannabis Conference
On Oct. 21, Mr. Thut will participate in a panel on M&A trends in the cannabis industry at 11:15 a.m. ET at Convene’s 117 West 46th St. location in New York City.

Benzinga Cannabis Capital Conference
On Oct. 22-23, Mr. Thut and Mr. Krane will give a company presentation and participate in one-on-one meetings at the Palmer House in Chicago.

About 4Front Ventures Corp.
4Front is a cannabis company designed for long-term success and built upon battle-tested operating capabilities at scale, experienced and committed leadership, a strategic asset base, and a commitment to being a magnet for talent. From plant genetics to the cannabis retail experience, 4Front’s team applies expertise across the value chain. 4Front has invested heavily to assemble a comprehensive collection of management skills and hands-on operating expertise to capitalize on the unique growth opportunity being afforded by the increased legalization of cannabis. For more information, visit 4Front’s website.  

Investor Contact
Andrew Thut, Chief Investment Officer 
IR@4frontventures.com
602-633-3067

Media Contact
Anne Donohoe / Nick Opich
KCSA Strategic Communications 
adonohoe@kcsa.com / nopich@kcsa.com 
212-896-1265 / 212-896-1206

This news release was prepared by management of 4Front Ventures, which takes full responsibility for its contents. The Canadian Securities Exchange (“CSE”) has not reviewed and does not accept responsibility for the adequacy of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in 4Front Ventures’ periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to future developments and the business and operations of 4Front Ventures, developments with respect to legislative developments in the United States and the proposed trading dated of the resulting issuer.

Although 4Front Ventures has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under U.S. federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. 4Front Ventures disclaims any intention or obligation to update or revise such information, except as required by applicable law, and 4Front Ventures does not assume any liability for disclosure relating to any other company mentioned herein.

The post 4Front Announces Upcoming Conference Participation appeared first on 4Front.

from 4Front https://ift.tt/2ovWOCe